Global Neurodegenerative Diseases Market Research Report 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 102

Report ID: 12240

Neurodegenerative diseases are becoming increasingly prevalent due to an aging population, but this diverse therapy area remains largely untreatable with current therapies. Neurodegenerative diseases are characterized by neuronal death within the brain and/or central nervous system (CNS), leading to progressive decline in functional neurological capacities. It has a devastating effect on quality of life and independence, often requiring full-time care during the later disease stages.

The global Neurodegenerative Diseases market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Neurodegenerative Diseases volume and value at global level, regional level and company level. From a global perspective, this report represents overall Neurodegenerative Diseases market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Novartis
Merck Serono
Teva Pharmaceutical
UCB
Pfizer
Biogen Idec
Bayer Schering Pharma AG
Boehringer Ingelheim
Addex Pharmaceutical
Amarin
AstraZeneca
Asubio Pharmaceutical
Bial
Alector
Yumanity Therapeutics
Eisai
H.Lundbeck A/S
Jiangsu Hansoh Pharmaceutical
Yangtze River Pharmaceutical Group
Chongqing Zein Pharmaceutical

Segment by Regions
North America
Europe
China
Japan

Segment by Type
NMDA
SSRIs
Dopamine Inhibitors

Segment by Application
Parkinson’s disease
Huntington disease
Amyotrophic Lateral Sclerosis
Alzheimer’s disease

Table of Contents

Executive Summary
1 Neurodegenerative Diseases Market Overview
1.1 Product Overview and Scope of Neurodegenerative Diseases
1.2 Neurodegenerative Diseases Segment by Type
1.2.1 Global Neurodegenerative Diseases Production Growth Rate Comparison by Type (2014-2025)
1.2.2 NMDA
1.2.3 SSRIs
1.2.4 Dopamine Inhibitors
1.3 Neurodegenerative Diseases Segment by Application
1.3.1 Neurodegenerative Diseases Consumption Comparison by Application (2014-2025)
1.3.2 Parkinson’s disease
1.3.3 Huntington disease
1.3.4 Amyotrophic Lateral Sclerosis
1.3.5 Alzheimer’s disease
1.4 Global Neurodegenerative Diseases Market by Region
1.4.1 Global Neurodegenerative Diseases Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Neurodegenerative Diseases Market Size
1.5.1 Global Neurodegenerative Diseases Revenue (2014-2025)
1.5.2 Global Neurodegenerative Diseases Production (2014-2025)

2 Global Neurodegenerative Diseases Market Competition by Manufacturers
2.1 Global Neurodegenerative Diseases Production Market Share by Manufacturers (2014-2019)
2.2 Global Neurodegenerative Diseases Revenue Share by Manufacturers (2014-2019)
2.3 Global Neurodegenerative Diseases Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Neurodegenerative Diseases Production Sites, Area Served, Product Types
2.5 Neurodegenerative Diseases Market Competitive Situation and Trends
2.5.1 Neurodegenerative Diseases Market Concentration Rate
2.5.2 Neurodegenerative Diseases Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Neurodegenerative Diseases Production Market Share by Regions
3.1 Global Neurodegenerative Diseases Production Market Share by Regions
3.2 Global Neurodegenerative Diseases Revenue Market Share by Regions (2014-2019)
3.3 Global Neurodegenerative Diseases Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Neurodegenerative Diseases Production
3.4.1 North America Neurodegenerative Diseases Production Growth Rate (2014-2019)
3.4.2 North America Neurodegenerative Diseases Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Neurodegenerative Diseases Production
3.5.1 Europe Neurodegenerative Diseases Production Growth Rate (2014-2019)
3.5.2 Europe Neurodegenerative Diseases Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China Neurodegenerative Diseases Production (2014-2019)
3.6.1 China Neurodegenerative Diseases Production Growth Rate (2014-2019)
3.6.2 China Neurodegenerative Diseases Production, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan Neurodegenerative Diseases Production (2014-2019)
3.7.1 Japan Neurodegenerative Diseases Production Growth Rate (2014-2019)
3.7.2 Japan Neurodegenerative Diseases Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Neurodegenerative Diseases Consumption by Regions
4.1 Global Neurodegenerative Diseases Consumption by Regions
4.2 North America Neurodegenerative Diseases Consumption (2014-2019)
4.3 Europe Neurodegenerative Diseases Consumption (2014-2019)
4.4 China Neurodegenerative Diseases Consumption (2014-2019)
4.5 Japan Neurodegenerative Diseases Consumption (2014-2019)

5 Global Neurodegenerative Diseases Production, Revenue, Price Trend by Type
5.1 Global Neurodegenerative Diseases Production Market Share by Type (2014-2019)
5.2 Global Neurodegenerative Diseases Revenue Market Share by Type (2014-2019)
5.3 Global Neurodegenerative Diseases Price by Type (2014-2019)
5.4 Global Neurodegenerative Diseases Production Growth by Type (2014-2019)

6 Global Neurodegenerative Diseases Market Analysis by Applications
6.1 Global Neurodegenerative Diseases Consumption Market Share by Application (2014-2019)
6.2 Global Neurodegenerative Diseases Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Neurodegenerative Diseases Business
7.1 Novartis
7.1.1 Novartis Neurodegenerative Diseases Production Sites and Area Served
7.1.2 Neurodegenerative Diseases Product Introduction, Application and Specification
7.1.3 Novartis Neurodegenerative Diseases Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
7.2 Merck Serono
7.2.1 Merck Serono Neurodegenerative Diseases Production Sites and Area Served
7.2.2 Neurodegenerative Diseases Product Introduction, Application and Specification
7.2.3 Merck Serono Neurodegenerative Diseases Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business and Markets Served
7.3 Teva Pharmaceutical
7.3.1 Teva Pharmaceutical Neurodegenerative Diseases Production Sites and Area Served
7.3.2 Neurodegenerative Diseases Product Introduction, Application and Specification
7.3.3 Teva Pharmaceutical Neurodegenerative Diseases Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business and Markets Served
7.4 UCB
7.4.1 UCB Neurodegenerative Diseases Production Sites and Area Served
7.4.2 Neurodegenerative Diseases Product Introduction, Application and Specification
7.4.3 UCB Neurodegenerative Diseases Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served
7.5 Pfizer
7.5.1 Pfizer Neurodegenerative Diseases Production Sites and Area Served
7.5.2 Neurodegenerative Diseases Product Introduction, Application and Specification
7.5.3 Pfizer Neurodegenerative Diseases Production, Revenue, Price and Gross Margin (2014-2019)
7.5.4 Main Business and Markets Served
7.6 Biogen Idec
7.6.1 Biogen Idec Neurodegenerative Diseases Production Sites and Area Served
7.6.2 Neurodegenerative Diseases Product Introduction, Application and Specification
7.6.3 Biogen Idec Neurodegenerative Diseases Production, Revenue, Price and Gross Margin (2014-2019)
7.6.4 Main Business and Markets Served
7.7 Bayer Schering Pharma AG
7.7.1 Bayer Schering Pharma AG Neurodegenerative Diseases Production Sites and Area Served
7.7.2 Neurodegenerative Diseases Product Introduction, Application and Specification
7.7.3 Bayer Schering Pharma AG Neurodegenerative Diseases Production, Revenue, Price and Gross Margin (2014-2019)
7.7.4 Main Business and Markets Served
7.8 Boehringer Ingelheim
7.8.1 Boehringer Ingelheim Neurodegenerative Diseases Production Sites and Area Served
7.8.2 Neurodegenerative Diseases Product Introduction, Application and Specification
7.8.3 Boehringer Ingelheim Neurodegenerative Diseases Production, Revenue, Price and Gross Margin (2014-2019)
7.8.4 Main Business and Markets Served
7.9 Addex Pharmaceutical
7.9.1 Addex Pharmaceutical Neurodegenerative Diseases Production Sites and Area Served
7.9.2 Neurodegenerative Diseases Product Introduction, Application and Specification
7.9.3 Addex Pharmaceutical Neurodegenerative Diseases Production, Revenue, Price and Gross Margin (2014-2019)
7.9.4 Main Business and Markets Served
7.10 Amarin
7.10.1 Amarin Neurodegenerative Diseases Production Sites and Area Served
7.10.2 Neurodegenerative Diseases Product Introduction, Application and Specification
7.10.3 Amarin Neurodegenerative Diseases Production, Revenue, Price and Gross Margin (2014-2019)
7.10.4 Main Business and Markets Served
7.11 AstraZeneca
7.12 Asubio Pharmaceutical
7.13 Bial
7.14 Alector
7.15 Yumanity Therapeutics
7.16 Eisai
7.17 H.Lundbeck A/S
7.18 Jiangsu Hansoh Pharmaceutical
7.19 Yangtze River Pharmaceutical Group
7.20 Chongqing Zein Pharmaceutical

8 Neurodegenerative Diseases Manufacturing Cost Analysis
8.1 Neurodegenerative Diseases Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Neurodegenerative Diseases
8.4 Neurodegenerative Diseases Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.2 Neurodegenerative Diseases Distributors List
9.3 Neurodegenerative Diseases Customers

10 Market Dynamics
10.1 Market Trends
10.2 Opportunities
10.3 Market Drivers
10.4 Challenges
10.5 Influence Factors

11 Global Neurodegenerative Diseases Market Forecast
11.1 Global Neurodegenerative Diseases Production, Revenue Forecast
11.1.1 Global Neurodegenerative Diseases Production Growth Rate Forecast (2019-2025)
11.1.2 Global Neurodegenerative Diseases Revenue and Growth Rate Forecast (2019-2025)
11.1.3 Global Neurodegenerative Diseases Price and Trend Forecast (2019-2025)
11.2 Global Neurodegenerative Diseases Production Forecast by Regions (2019-2025)
11.2.1 North America Neurodegenerative Diseases Production, Revenue Forecast (2019-2025)
11.2.2 Europe Neurodegenerative Diseases Production, Revenue Forecast (2019-2025)
11.2.3 China Neurodegenerative Diseases Production, Revenue Forecast (2019-2025)
11.2.4 Japan Neurodegenerative Diseases Production, Revenue Forecast (2019-2025)
11.3 Global Neurodegenerative Diseases Consumption Forecast by Regions (2019-2025)
11.3.1 North America Neurodegenerative Diseases Consumption Forecast (2019-2025)
11.3.2 Europe Neurodegenerative Diseases Consumption Forecast (2019-2025)
11.3.3 China Neurodegenerative Diseases Consumption Forecast (2019-2025)
11.3.4 Japan Neurodegenerative Diseases Consumption Forecast (2019-2025)
11.4 Global Neurodegenerative Diseases Production, Revenue and Price Forecast by Type (2019-2025)
11.5 Global Neurodegenerative Diseases Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer